The concentration of systemic inflammatory cytokines were not associated with differences in CYP2C19 and CYP2D6 activity15,20, but elevated CRP was shown to correlate with reduced CYP3A4 activity in patients with advanced cancer and was strongly positively correlated with levels of serum IL-625. This evidence concerns the gene CYP2C19 and cancer.